Researchers on a mission to fight deadly childhood cancer
Australian researchers aim to improve risk classification and identify therapeutic drugs for neuroblastoma, the deadliest solid tumour in children under five. They will use patient data and genetically engineered stem cells to model the disease process and predict patient outcomes.